Aldebaran Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$201K Buy
688
+1
+0.1% +$329 0.19% 76
2025
Q4
$240K Buy
687
+1
+0.1% +$338 0.22% 69
2025
Q3
$222K Buy
686
+1
+0.1% +$311 0.22% 73
2025
Q2
$266K Buy
685
+1
+0.1% +$402 0.29% 65
2025
Q1
$298K Hold
684
0.36% 58
2024
Q4
$252K Buy
684
+1
+0.1% +$418 0.29% 66
2024
Q3
$355K Buy
683
+1
+0.1% +$534 0.42% 49
2024
Q2
$370K Hold
682
0.48% 42
2024
Q1
$353K Buy
682
+1
+0.1% +$497 0.5% 46
2023
Q4
$321K Buy
681
+1
+0.1% +$462 0.47% 48
2023
Q3
$296K Hold
680
0.46% 52
2023
Q2
$302K Buy
680
+1
+0.1% +$461 0.41% 51
2023
Q1
$312K Sell
679
-100
-13% -$47.6K 0.4% 52
2022
Q4
$399K Buy
779
+1
+0.1% +$508 0.43% 56
2022
Q3
$360K Hold
778
0.4% 60
2022
Q2
$366K Buy
+778
New +$385K 0.39% 58
2014
Q3
Sell
-2,509
Closed -$270K 117
2014
Q2
$270K Buy
+2,509
New +$259K 0.21% 101

Other funds holding ELV

Aldebaran Financial's ELV Position: Q1 2026 in Review

Aldebaran Financial increased its Elevance Health (ELV) stake by 0.15% in Q1 2026, buying an estimated $329 and bringing the position to 688 shares worth $201K. The position accounts for 0.19% of the portfolio, ranked #76.

Aldebaran Financial first reported a position in ELV in Q2 2014 and has held it in 17 quarters since. The position peaked at $399K in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Aldebaran Financial held 688 shares of Elevance Health worth $201K as of Q1 2026.
  • Aldebaran Financial bought 1 Elevance Health share in Q1 2026, an estimated $329.
  • Elevance Health made up 0.19% of Aldebaran Financial's portfolio in Q1 2026, its #76 holding.
  • Aldebaran Financial first reported a position in Elevance Health in Q2 2014 and has held it in 17 quarters since.
  • Aldebaran Financial's Elevance Health position peaked at $399K in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Aldebaran Financial's 13F filing for Q1 2026, filed 14 May 2026.